Here are relevant reports on : genomic-diagnostics-market
-
ASEAN Point of Care Diagnostics Market by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), Technology (Lateral Flow Assays, Biochemistry, MDx), End User (Home Care, Hospitals) - Forecast to 2030
Global ASEAN point of care diagnostics market valued at $1.05B in 2024, reached $1.08B in 2025, and is projected to grow at a robust 4.7% CAGR, hitting $1.36B by 2030. The increasing incidence of chronic conditions, especially diabetes, generates the demand for regular monitoring and early detection, boosting the need for rapid & accurate POC testing solutions
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Medical Gas and Equipment Market by Type (Pure Medical Gases/Mixtures), Medical Gas Equipment (Flowmeter, Medical Air Compressor)), Application (Therapeutics (Respiratory), Diagnostics), End User (Hospitals, Home Healthcare) - Global Forecast to 2029
The global medical gas and equipment market, valued at US$17.65 billion in 2022, stood at US$19.90 billion in 2023 and is projected to advance at a resilient CAGR of 5.8% from 2023 to 2029, culminating in a forecasted valuation of US$26.44 billion by the end of the period. The market is expanding significantly due to rising respiratory illnesses that necessitate frequent medical gas treatment and growing demand for effective and safe gas delivery systems. Increased emphasis on home healthcare services and regulatory support for safer gas delivery methods are expected to boost market growth.
- Published: September 2024
- Price: $ 7150
- TOC Available:
-
Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030
The global veterinary infectious disease diagnostics market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$4.22 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
In Vitro Diagnostics (IVD) Quality Control Market by Product & Service (QC (Plasma, Serum, Blood), Solutions), Technology (Immunoassay, MDx, Microbiology, Hematology), Manufacturer (Third-party, OEM), End User (Hospitals, Labs) - Global Forecast to 2030
The global IVD quality controls market, valued at US$1.58 billion in 2024, stood at US$1.65 billion in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2025 to 2030, culminating in a forecasted valuation of US$2.15 billion by the end of the period. The IVD quality controls market is witnessing substantial growth, driven by several key factors.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Hematology), Application (Clinical Pathology, Virology), Animal (Dogs, Cats, Horses), End User (Diagnostic Laboratories) - Global Forecast to 2029
The global companion animal diagnostics market, valued at US$2.75 billion in 2023, stood at US$2.99 billion in 2024 and is projected to advance at a resilient CAGR of 8.8% from 2024 to 2029, culminating in a forecasted valuation of US$4.55 billion by the end of the period. The growing demand for rapid tests and portable instruments for point-of-care (POC) services is offering growth opportunities for players in the companion animal diagnostics market.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Cystatin C Assay Market by Product (Analyzers, Kits, Reagents), Method (ELISA, PETIA, IFA, CLIA, PENIA), Application (Diagnostics, Research), Sample Type (Blood, Urine), End User (Hospitals, Clinical Laboratories) & Region - Global Forecast to 2028
The global cystatin C assay market, valued at US$352 million in 2022, stood at US$377 million in 2023 and is projected to advance at a resilient CAGR of 7.5% from 2023 to 2028, culminating in a forecasted valuation of US$540 million by the end of the period.The growth of this market is majorly driven by the Increasing adoption of POC testing and presence of supportive government policies. However, raising awareness among healthcare providers about the benefits of cystatin C testing can be challenging.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Cognitive Assessment and Training in Healthcare Market by Assessment Type (Pen-and-Paper Based, Hosted, and Biometrics), Components, Application (Clinical Trial, Screening & Diagnostics, Brain Training, Academic Research), & Region - Global forecast to 2021
Cognitive impairment can occur in early childhood or late adulthood. There are various reasons for it, which can be reversible or irreversible. Early causes may include malnutrition, prenatal drug exposure, genetic syndromes, and chromosome abnormalities. The brain retains its neuroplasticity till late adulthood; therefore, there has been a growing demand for cognitive assessment and training. MarketsandMarkets predicts the global cognitive assessment and training in healthcare market to grow from USD 962.0 Million in 2016 to USD 4,127.2 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 33.8%. The year 2015 has been considered as the base year, while the forecast period is 2016–2021.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
In Situ Hybridization Market by Offering (Consumables, Instruments, Software), Technology (FISH (DNA FISH, RNA, PNA), CISH), Application (Cancer Diagnostics, Research, Discovery), End User (Hospitals, Pharma & Biotech, Academia) - Global Forecast to 2030
The global in situ hybridization market, valued at US$1.55 billion in 2024, stood at US$1.64 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$2.35 billion by the end of the period. The growth in the field of in situ hybridization (ISH) is significantly driven by ongoing advancements in technology, including high-sensitivity probes, automated systems, and multiplexing solutions.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Oligonucleotide Synthesis Market by Product ((Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic (Rare Diseases), Research, Diagnostics) - Global Forecast to 2030
The global oligonucleotide synthesis market, valued at US$8.9 billion in 2024, stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 18.6% from 2025 to 2030, culminating in a forecasted valuation of US$24.7 billion by the end of the period. The oligonucleotide synthesis market is experiencing significant growth, driven by the increasing applications of synthesized oligonucleotides in therapeutics & diagnostics. This growth is supported by technological advancements and rising investments in life sciences research and synthetic biology.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Transcutaneous Monitors Market by Type (Adult Wound Healing, Neonatal Care), Application (Sleep Diagnostics, Respiratory Care, Plastic surgery) & End User (Hospitals, Speciality Clinic, Neonatal Intensive Care, Diagnostic Center) - Global Forecast to 2023
The global transcutaneous monitors market is expected to reach USD 206.9 million by 2023 from USD 154.6 million in 2018, growing at a CAGR of 6.0%. Increasing demand for non-invasive monitoring; rising risk of respiratory diseases; increasing healthcare expenditure in developing economies such as India, China, Brazil; and technological advancement leading to more accuracy are some of the major factors driving the growth of the global transcutaneous monitors market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
